FIELD: chemistry.
SUBSTANCE: invention relates to novel 5-[(4-alkyl)-1,2,3-triazol-1-yl]methyl derivatives of 2'-deoxyuridine and 2'-deoxycytidine, which inhibit growth of Mycobacterium tuberculosis, including drug-resistant strains, having formula 1 and 2,
, 
,
where R=CnH2n+1, n=8, 10, 12.
EFFECT: improved properties of derivatives.
1 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRANOINDOLES WITH ANTI-TUBERCULOSIS ACTIVITY | 2018 |
|
RU2675240C1 |
| OLIGOGLYCOL-CARBONATE PRODRUGS BASED ON 5-MODIFIED 2'-DEOXYURIDINES EXHIBITING ANTIBACTERIAL ACTIVITY | 2022 |
|
RU2808726C1 |
| QUATERNARY AMMONIUM DERIVATIVES OF 2-AMINOTHIOPHEN-3-CARBOXYLATES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2016 |
|
RU2629369C1 |
| 2'-AMINO-2'-DEOXYNUCLEOSIDES AS INHIBITORS IF MEASLES AND MARBURG VIRUSUS REPRODUCTION | 2003 |
|
RU2264409C2 |
| NEW N-MODIFIED 5-METHYL-2'-DEOXYCYTIDINES EXHIBITING ANTIMICOTIC ACTIVITY | 2021 |
|
RU2766333C1 |
| MMPL3 INHIBITORS, COMPOSITIONS BASED ON THEM AND WAYS OF THEIR APPLICATION | 2019 |
|
RU2795229C2 |
| NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR TREATMENT OF MAMMALIAN INFECTIONS AND NEW METABOLIC MECHANISM | 2017 |
|
RU2752568C2 |
| ANTI-INFECTIOUS COMPOUNDS | 2014 |
|
RU2734760C2 |
| ALICYCLIC COMPOUNDS, A METHOD OF THEIR SYNTHESIS, A PHARMACEUTICAL COMPOSITION SHOWING ANTI-INFLAMMATORY ACTIVITY AND A METHOD OF TREATMENT OF PATIENTS WITH INFLAMMATION | 1994 |
|
RU2130011C1 |
| ANTIFUNGAL SEMI-SYNTHETIC POLYENE ANTIBIOTIC, WATER-SOLUBLE SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2018 |
|
RU2688658C1 |
